2016 European Guidelines on Cardiovascular Disease Prevention in Clinical Practice

This is the European counterpart to the American prevention guidelines — the comprehensive document that shapes how cardiovascular disease is prevented across much of the continent. Assembled by a joint task force spanning multiple societies, it covers the whole field in one place: who is at risk, and what to do about it.

Its structural signature is the SCORE system, the European risk engine that estimates a patient’s 10-year risk of fatal cardiovascular disease, calibrated to local populations rather than borrowed from American cohorts. From that estimate the guideline builds outward — lifestyle as the universal foundation, then risk-matched targets for lipids and blood pressure, then pharmacotherapy. It addresses both primary prevention in the healthy and secondary prevention in those who already have disease.

The honest qualifier is geography and vintage. SCORE is tuned to European populations and frames risk around cardiovascular death rather than total events, which makes the numbers less portable elsewhere. And on lipids specifically, this 2016 edition was superseded three years later by the 2019 ESC/EAS dyslipidaemia guidelines, which set considerably more aggressive LDL targets as the PCSK9 trial data matured.

We rate the evidence very strong. It is a rigorous, broadly endorsed, and influential synthesis — best read today as the comprehensive prevention framework of its moment, with the lipid-specific recommendations now carried forward by its newer descendants.